Influence of the vascular damaging agents DMXAA and ZD6126 on hypericin distribution and accumulation in RIF-1 tumors

Neutrophil Influx and Chemokine Production during the Early Phases of the Antitumor Response to the Vascular Disrupting Agent DMXAA (ASA404)

(2015) Liang-Chuan S. Wang et al.   NEOPLASIA

Convection-enhanced delivery of131I-chTNT-1/B mAB for treatment of high-grade adult gliomas

(2011) Alia Hdeib et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-DOTA-Hypericin

(2011) S. Song et al.   JOURNAL OF NUCLEAR MEDICINE

A Dual-targeting Anticancer Approach: Soil and Seed Principle

(2011) Junjie Li et al.   RADIOLOGY

Disrupting established tumor blood vessels

(2010) Mark J. McKeage et al.   CANCER

Morphological, functional and metabolic imaging biomarkers: assessment of vascular-disrupting effect on rodent liver tumours

(2010) Huaijun Wang et al.   EUROPEAN RADIOLOGY

Microtubule depolymerizing vascular disrupting agents: novel therapeutic agents for oncology and other pathologies

(2010) Chryso Kanthou et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Hypericin as a Marker for Determination of Tissue Viability After Intratumoral Ethanol Injection in a Murine Liver Tumor Model

(2007) Marie Van de Putte et al.   ACADEMIC RADIOLOGY